Showing results (2001-2010 of 2,274) with videos related to

Sort By:
Pageof 228
The Journal of Cell Biology|June 26, 2002
Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon proteaseOsamu Hori, Fusae Ichinoda, Takashi Tamatani, et al.
Pharmacology Research & Perspectives|September 12, 2019
Discovery and characterization of a small-molecule enteropeptidase inhibitor, SCO-792Masako Sasaki, Ikuo Miyahisa, Sachiko Itono, et al.
Scientific Reports|June 24, 2021
Diurnal rhythms of urine volume and electrolyte excretion in healthy young men under differing intensities of daytime light exposureIsuzu Nakamoto, Sayaka Uiji, Rin Okata, et al.
British Journal of Haematology|December 19, 1998
Plasma thrombopoietin (TPO) levels and expression of TPO receptor on platelets in patients with myelodysplastic syndromesH Tamura, K Ogata, S Luo, et al.
Plos One|August 1, 2015
The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter RegistryJun Fujita, Shun Kohsaka, Ikuko Ueda, et al.
Journal of Human Genetics|January 18, 2018
Novel recessive mutations in MSTO1 cause cerebellar atrophy with pigmentary retinopathyKazuhiro Iwama, Toru Takaori, Ai Fukushima, et al.
Scientific Reports|July 19, 2020
Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivoHajime Ichimura, Shin Kadota, Toshihide Kashihara, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 2016
Multi-institutional Validation Study of Commercially Available Deformable Image Registration Software for Thoracic ImagesNoriyuki Kadoya, Yujiro Nakajima, Masahide Saito, et al.
International Journal of Hematology|August 26, 2009
Lenalidomide is active in Japanese patients with symptomatic anemia in low- or intermediate-1 risk myelodysplastic syndromes with a deletion 5q abnormalityHironori Harada, Mitsumasa Watanabe, Kenshi Suzuki, et al.
Leukemia Research|December 17, 2011
Morphologic analysis in myelodysplastic syndromes with del(5q) treated with lenalidomide. A Japanese multiinstitutional studyAkira Matsuda, Masafumi Taniwaki, Itsuro Jinnai, et al.
Pageof 228